Related Experiment Video
Updated: Jul 10, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Standardized lifetime risk.
1Department of Mathematics, Statistics, and Epidemiology, Imperial Cancer Research Fund, London, United Kingdom.
American Journal of Epidemiology
|April 30, 1999
Summary
This study introduces two new, easy-to-understand risk measures: standardized lifetime risk and standardized years of life lost. These metrics simplify public health data communication and disease impact analysis.
Area of Science:
- Epidemiology
- Biostatistics
- Public Health
Background:
- Standardized rates are crucial for comparing health data across populations.
- Existing measures can be complex and require specialized training for interpretation.
- Clearer risk communication is essential for public health policy and understanding.
Purpose of the Study:
- To introduce two novel, standardized risk measures: standardized lifetime risk and standardized number of years of life lost.
- To provide standardizing weights based on 1992 data from England and Wales.
- To illustrate the utility of these new measures with practical examples.
Main Methods:
- Development of two new standardized risk measures.
- Application of standardizing weights derived from 1992 England and Wales mortality data.
- Illustrative examples demonstrating the application and interpretation of the new measures.
Main Results:
- The proposed measures offer advantages of standardized rates while being more intuitively understood.
- Examples demonstrate their use in examining trends, comparing disease impact, and international comparisons.
- A shift towards more accessible risk communication is advocated, e.g., 41/1,000 women dying of breast cancer versus a complex rate.
Conclusions:
- The new standardized lifetime risk and years of life lost measures enhance risk communication.
- These measures facilitate clearer analysis of disease trends, public health impact, and international comparisons.
- Adoption of these measures can improve public understanding of health risks and disease burden.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:22Life Tables
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:11Hazard Rate
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...